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40 The Journal of Thoracic and Cardiobjectives: The transannular patch used to relieve right ventricular outflow tract
bstruction in children with tetralogy of Fallot may result in pulmonary insuffi-
iency. We hypothesized that pulmonary valve cusp augmentation with pericardium
ould decrease pulmonary insufficiency and improve the early outcome for transatrial–
ranspulmonary tetralogy of Fallot repair requiring transannular patch.
ethods: Since November 2001, 41 patients with tetralogy of Fallot and 2 patients
ith isolated pulmonary valve stenosis had relief of right ventricular outflow tract
bstruction with either a transannular patch plus pulmonary valve cusp augmenta-
ion (n  18) or a transannular patch alone (n  25). Data were retrospectively
ollected.
esults: The median age (5.3 vs 3.2 months; P  .09) and weight (6.4 vs 5.2 kg;
 .3) were similar for the cusp augmentation and transannular patch groups,
espectively. The diameter of the pulmonary valve annulus (6.4 vs 6.0 mm; P .57)
nd the McGoon index (1.47 vs 1.69, P  .75) were also similar. The mean aortic
lamp time (48  18 minutes vs 52  19 minutes; P  .46) and median
ardiopulmonary bypass time (89 vs 91 minutes; P  .9) did not differ. One patient
ith a transannular patch died of multiorgan system failure. Patients with a pulmo-
ary valve cusp augmentation had a shorter duration of intubation (1 vs 3 days; P
.001) and intensive care unit stay (2 vs 8 days; P  .001). Thirteen patients with
transannular patch and 1 patient with a pulmonary valve cusp augmentation
equired inotropic support for more than 72 hours (P  .001). Discharge echocar-
iograms demonstrated moderate or severe pulmonary insufficiency in 5 patients
ith a pulmonary valve cusp augmentation and in 21 patients with a transannular
atch (P  .001). At 7.5 months, 3 patients (17%) with a pulmonary valve cusp
ugmentation had progression of pulmonary insufficiency.
onclusions: Augmentation of a pulmonary valve cusp reduces the incidence of
linically significant postoperative pulmonary insufficiency. This technique may
mprove the early outcome for children with tetralogy of Fallot requiring a transan-
ular patch.
he combination of a ventriculotomy and free pulmonary insufficiency (PI),
both associated with the transannular patch, is implicated in the deterioration
of right ventricular function and the development of arrhythmias after
etralogy of Fallot (TOF) repair. In the current era, in which the immediate outcome
f TOF repair is expected to be excellent irrespective of surgical technique and
iming of the repair, the goal of the surgical treatment of TOF should be the
voidance of long-term complications and a low probability of early and late
eoperations. At the University of California at San Francisco (UCSF), since
ovember of 2001, we have used the transatrial–transpulmonary approach for repair
vascular Surgery ● March 2007
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Df TOF to avoid an extensive right ventriculotomy.1,2 In the
ubset of patients who did not have adequate relief of the
ight ventricular outflow tract (RVOT) obstruction with
omplete sparing of the pulmonary valve, we extended the
ulmonary artery incision for approximately 10 to 15 mm
nto the right ventricular free wall. To further decrease the
egree of postoperative PI, we used the technique of aug-
entation of the native pulmonary valve tissue with autol-
gous pericardium, originally described by Sung and asso-
iates.3 We hypothesized that it would lead to an improved
arly outcome for transatrial–transpulmonary TOF repair.
atients and Methods
atient Population
he Committee on Human Research at UCSF approved the study.
The study population consisted of all patients with TOF (n 
1) or isolated pulmonary valve stenosis (n  2) who underwent
ransatrial–transpulmonary repair at UCSF Children’s Hospital
etween November 2001 and August 2005 and required division
f the pulmonary valve annulus for adequate relief of RVOT
bstruction. Patients with TOF who had repair without division of
he pulmonary annulus (pulmonary valve–sparing operation) were
xcluded, as were those with discontinuous pulmonary arteries,
ulmonary atresia and ventricular septal defect, atrioventricular
eptal defect, and absent pulmonary valve syndrome. Eighteen
atients had pulmonary valve cusp augmentation with an autolo-
ous pericardial patch according to the technique described by
ung and associates.3 During the same period of time, 25 patients
nderwent repair with a transannular patch and were used as
ontrols. The patients were not randomized, and each of the 2
rimary surgeons in the study used both techniques. There was not
clearly defined indication for one procedure or the other.
perative Details
he operative technique is outlined in Figure 1. A patch of autol-
gous pericardium was harvested and treated with 0.2% glutaral-
ehyde for 10 minutes. Cardiopulmonary bypass was established
hrough bicaval and aortic cannulation. Systemic to pulmonary
rtery shunts, if present, were ligated after the beginning of car-
iopulmonary bypass. Moderate hypothermia was used (28°C-
2°C). The heart was arrested with antegrade cold blood cardio-
legia. The right atrium was opened longitudinally, and the left
eart was vented through the foramen ovale. A longitudinal inci-
ion was made in the main pulmonary artery and extended to the
nnulus of the pulmonary valve. The valve was inspected. If there
as significant commissural fusion or tethering of the leaflets to
Abbreviations and Acronyms
ICU  intensive care unit
PI  pulmonary insufficiency
RVOT right ventricular outflow tract
TOF  tetralogy of Fallot
UCSF  University of California at San Franciscohe pulmonary artery wall, these were sharply divided. Excision of d
The Journal of Thoraciche parietal extension of the infundibular septum was performed
hrough the tricuspid valve. Hegar dilators were then passed
hrough the tricuspid valve toward the main pulmonary artery. If
he diameter of the annulus was more than 2 standard deviations
z score  2) below the normal predicted annulus diameter for
he patient’s weight, the pulmonary annulus was divided.4 In the
ajority of cases the pulmonary valve was bicuspid with location
f the commissures at the 3 and 9 o’clock positions. An incision
as made in the middle of the anterior cusp and then extended to
he right ventricular free wall for approximately 10 to 15 mm.
hen the pulmonary valve commissures were located at the 6 and
2 o’clock positions or the commissures were anterior and poste-
ior but located off the midline, we divided the pulmonary valve at
r near the anterior commissure to preserve as much valve tissue
s possible, as described by Sung and associates.3 The division of
he remaining obstructing muscular and fibrous bands was per-
ormed through the ventriculotomy. The ventricular septal defect
as closed through the tricuspid valve. The foramen ovale was
losed with a temporary purse string suture, the heart was de-aired,
nd the aortic clamp was removed.
Reconstruction of the RVOT was then performed. In patients
ho underwent RVOT reconstruction with a transannular patch, the
VOT and pulmonary arteriotomy were closed with an appropriately
ized single pericardial or polytetrafluoroethylene (Gore-Tex, WL
ore and Associates, Flagstaff, Ariz) patch. In patients who under-
ent the transannular patch plus reconstruction with the pulmonary
alve cusp augmentation technique, a triangular glutaraldehyde-
reated autologous pericardial patch was sutured in the endocardium
rom the most inferior aspect of the right ventriculotomy all the way
p to the hinge point of the anterior cusp and then along the
ivided edge of the valve on either side. When the anterior cusp
as small or the anterior commissure was located at the 12
’clock position, the patch was anchored to the main pulmonary
rtery. In patients in whom the commissure was eccentric, the
atch was sewn to the main pulmonary artery on 1 side and to
he free edge of the leaflet on the other side. Then a second
atch was used to close the RVOT and the pulmonary arteriot-
my, thus recreating a sinus over the augmented valve leaflet.
linical Data
he medical records of all patients were reviewed. We recorded
emographic data, previous operations, catheterization procedures,
nd associated comorbidities, including genetic syndromes. For
ach patient we gathered data on the operative repair including
ardiopulmonary bypass time, aortic clamp time, description of the
VOT management, and additional surgical procedures per-
ormed. The postoperative course was then reviewed. The date of
xtubation, the date of discharge from the intensive care unit
ICU), and the date of discharge from the hospital were used to
alculate days intubated, days in the ICU, and days hospitalized.
ll of the complications were recorded. Finally, the condition
uring the last clinic visit of the patients with a pulmonary valve
usp augmentation was recorded. Late complications, follow-up
nterventions, and reoperations were noted.
chocardiographic Data
ll preoperative and postoperative echocardiograms and echocar-
iographic reports were reviewed. The preoperative pulmonary
and Cardiovascular Surgery ● Volume 133, Number 3 641
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Dalve annulus was measured in a modified parasternal long-axis
iew. The branch pulmonary artery diameter was measured in the
arasternal short-axis plane, and the McGoon index was calcu-
ated. Tricuspid regurgitation was graded as follows: 0  none;
 trivial; 2  mild; 3  moderate; 4  severe. PI severity was
raded in a similar fashion. Patients with mild or less insufficiency
ere grouped and compared with those with moderate or severe
nsufficiency. For the patients who underwent pulmonary valve
usp augmentation with autologous pericardium, we reviewed the
ollow-up echocardiogram to investigate whether there was pro-
ression in the degree of PI.
tatistical Analysis
ariables with a normal distribution are expressed as the mean 
tandard deviation. Variables without a normal distribution are
xpressed as median and range. Differences were examined for
ignificance by univariate analysis (Student t test, chi-square test,
isher exact test, or Mann–Whitney U test as appropriate). All data
ere analyzed with Statistica 6.0 (StatSoft Inc, Tulsa, Okla). i
42 The Journal of Thoracic and Cardiovascular Surgery ● Marcesults
atient characteristics and preoperative transthoracic echocar-
iographic data are shown in Tables 1 and 2, respectively.
Mean aortic clamp time (48  18 minutes vs 52  19
inutes for transannular patch; P  .46) and median car-
iopulmonary bypass time (89 minutes vs 91 minutes for
ransannular patch; P  .9) were similar in the 2 groups.
ne patient with a transannular patch died. The patient was
34-week gestational age twin baby boy who never left the
ospital after birth and underwent operation at 6 weeks of
ge. Postoperatively he required extracorporeal membrane
xygenation twice for persistent low cardiac output from
ight ventricular diastolic dysfunction and intractable atrial
achyarrhythmias. Persistent large output bilateral chylotho-
aces and acute renal failure developed in the boy, which
ere treated with peritoneal dialysis. After a brief period of
Figure 1. A, Pulmonary cusp aug-
mentation repair technique. A
transannular incision has been
created according to calibration
of the RVOT diameter (see text).
The incision divides the anterior
pulmonary valve leaflet, although
the exact location will vary with
the valve orientation and mor-
phology. B, Pulmonary cusp aug-
mentation repair technique. A
triangular patch of glutaralde-
hyde-preserved autologous peri-
cardium is sutured to the epicar-
dial edge of the RVOT incision
and to the divided edges of the
valve leaflet. The leaflet dimen-
sions are based on the caliber of
a normal pulmonary valve diame-
ter and should provide sufficient
free edge diameter to ensure co-
aptation with the native valve
remnant. C, Pulmonary cusp aug-
mentation repair technique. A
second larger oval patch of the
same material is sutured to the
epicardial aspect of the RVOT in-
cision and to the edges of the
pulmonary arteriotomy, creating a
sinus anterior to the recon-
structed leaflet. PA, Pulmonary
artery; PV, pulmonary valve;
RVOT, right ventricular outflow
tract.mprovement, Staphylococcus epidermidis endocarditis de-
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Deloped that led to multiorgan system failure. He died on
ostoperative day 86.
The postoperative course and discharge data in the 2
roups of patients are shown in Table 3.
Of the 18 patients who underwent pulmonary valve cusp
ugmentation, 1 was lost to follow-up. Two patients re-
uired reintervention. One patient presented to the hospital
months postoperatively with a delayed pericardial effu-
ion and required a pericardial window. The cause of this
ffusion was unclear. The second patient was symptomatic
ith persistent subvalvar pulmonary stenosis. She under-
ent operative RVOT muscle bundle resection 2 years after
er original repair. This patient had moderate PI at dis-
harge, and the degree of PI did not change during follow-
p. At a median follow-up of 7.5 months (range 0-29
onths), 6 of the 17 patients (35.3%) had moderate or
evere PI at follow-up. Three patients (17%) who underwent
ulmonary valve cusp augmentation had progression of PI
hen compared with the degree of PI at discharge.
iscussion
here is a current trend for complete repair of TOF in early
nfancy. This strategy was first applied in neonates with
ABLE 1. Patient characteristics
atient characteristics
TAP  PV valve
cusp augmentation
n  18
TAP
n  25 P
ale:female 7:11 12:13 .55
Age (mo) 5.3 (1.3-9.1) 3.2 (1.5-62.5) .09
Weight (kg) 6.4 (2.9-9.1) 5.2 (3.3-14.3) .3
revious modified BT shunt 3 (16%) 3 (12%)
revious balloon valvotomy 1 1
dditional diagnosis
Right aortic arch 2
Bilateral SVC 1
PDA 1 4
Eccentric origin RCA 1
oonan’s syndrome 1
dditional operations
Branch PA plasty 1 (5%) 4 (16%)
Tricuspid valve repair 1
AP, Transannular patch; BT, Blalock–Taussig; SVC, superior vena cava;
DA, patent ductus arteriosus; RCA, right coronary artery; PA, pulmonary
rtery; PV, pulmonary valve. *Median/range.
ABLE 2. Preoperative transthoracic echocardiographic d
reoperative echocardiographic variable
TAP  PV
ulmonary annulus size mm (median/range)
reoperative RVOT gradient (mean/SD) 7
reoperative McGoon index (median/range)AP, Transannular patch; PV, pulmonary valve; RVOT, right ventricular outflow
The Journal of Thoracicnacceptable oxygen saturations5-7 and has been adopted by
ome centers as the preferred approach even the for mini-
ally cyanotic neonates.8,9 Although primary neonatal re-
air can be accomplished with excellent early results, it can
ead to routine use of a large ventriculotomy and repair with
transannular patch in up to 70% of patients. In fact, this
peration is remarkably similar to the technique described
y Lillehei in which ventriculotomy is used for VSD closure
n up to 96% of patients.10
The use of a transannular patch may result in free PI,
hich causes right ventricular dilation that in turn com-
resses the left ventricle. The functional reserve and myo-
ardial contractility of the right (and possibly left) ventricle
ecrease. These changes can be detected in experimental
odels as early as 3 months after the onset of PI.11 This
hysiology is well tolerated in the majority of patients for a
rolonged period of time,12-14 but some will eventually
xperience decreased exercise tolerance and progressive
ight ventricular dilation and failure.15,16 The exercise per-
ormance and the degree of right ventricular failure corre-
ate with the severity of PI.17,18 The chronic volume load to
he right ventricle after TOF repair leads to dilation of the
entricle and predisposes the patient to late life-threatening
entricular arrhythmias and sudden death.15,19
Several groups have described strategies to limit the size
f the right ventriculotomy and reduce the incidence of PI.
alved homografts and xenografts were proposed as the
ost anatomic and physiologic way to resolve RVOT ob-
truction, but all will eventually need replacement because
f patient growth and conduit deterioration.20 The use of a
onocusp valve created from pericardium, xenograft valve
usps, fascia lata, autologous pulmonary artery wall, or
olytetrafluoroethylene has been shown to decrease short-
erm PI.21-23 However, even the monocusp has limited du-
ability. Gundry and associates21 reported that by 24 months
nly 14% of their patients with a homograft monocusp-
earing transannular patch had a competent valve despite
xcellent short-term function. Similarly, in a report from the
niversity of Indiana most of the patients had deterioration
f the polytetrafluoroethylene monocusp valve function by
years, even though the valve function was still better
ompared with the free PI experienced by the patients with
 transannular patch.22 Other groups have abandoned the
e cusp augmentation
 18
TAP
n  25 P
m (4-9) 6.0 mm (4.5-11) .57
25 mm Hg 83.3  21 mm Hg .51
7 (1.1-2.1) 1.69 (1-2.3) .75ata
valv
n
6.4 m
8.5 
1.4tract; SD, standard deviation.
and Cardiovascular Surgery ● Volume 133, Number 3 643
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Donocusp because they did not think that it provided a
ignificant advantage for the patient.24
The Northwestern University group recommends avoid-
nce of a transannular patch with preservation of the annulus
f the pulmonary valve.24 They perform transatrial closure of
he ventricular septal defect, extensive commissurotomy,
ranspulmonary, and transatrial RVOT muscle resection, and,
hen needed, augmentation of the infundibulum with a
eparate patch that does not cross the annulus. They accept
right ventricular to left ventricular systolic pressure ratio
f 0.7, because their main goal is to preserve the annulus,
ore so than the valve cusps, explaining the 36% incidence
f PI at midterm follow-up. Only 2 of 73 patients who met
heir criteria required reoperation for residual stenosis at a
ean follow-up of approximately 3 years.24 In the subgroup
f patients who do not have adequate RVOT relief through
ransatrial and transpulmonary muscle bundle resection, it is
ot clear that patching of the outflow with preservation of
he annulus will offer an advantage in the long run over
ransannular patching. D’Udekem and associates25 re-
iewed 191 patients who had TOF repair between 1964
nd 1984 and concluded that a transannular patch does not
esult in a worse late functional outcome than patching of an
ncision limited to the right ventricle.
TOF can be reliably repaired through a transatrial and
ranspulmonary approach.1,2,26,27 This approach differs
rom the transventricular TOF repair in that the right ven-
ricular incision, if needed, extends just enough to relieve
he obstruction of the outflow tract. There is a suggestion
hat this approach results in a lesser degree of PI, lower
ncidence of arrhythmias, and better overall right ventricular
erformance.1,28
In our unit since November of 2001, we have used the
ransatrial–transpulmonary approach for TOF repair, fol-
owing the policy set forth by Dr Mee at Royal Children’s
ABLE 3. Postoperative clinical and transthoracic echoca
ariable
TAP  PV va
uration of intubation (median/range)
eintubations
neumonia
ersistent pleural effusion/chylothorax
notropic support  72 h
VT
CU stay (median/range)
ospital stay (median/range) 7
ischarge RVOT gradient (median/range) 13.5
oderate/severe PI on discharge
oderate/severe TR on discharge
AP, Transannular patch; SVT, supraventricular arrhythmia; ICU, intensive
ricuspid regurgitation; PV, pulmonary valve.ospital, Melbourne. Neonates with an unacceptable level R
44 The Journal of Thoracic and Cardiovascular Surgery ● Marcf hemoglobin saturation and/or hypercyanotic spells may
e palliated with a modified Blalock–Taussig shunt. Al-
hough there is documented morbidity and interval mortality
ith this approach,29 there are centers that report excellent
utcome and a risk of palliation that approaches 0% with the
se of this strategy.1,24 The pros and cons of this approach
ave been extensively discussed elsewhere and are beyond
he scope of the present study. We do make an effort to
omplete the repair without division of the annulus, al-
hough our target right to left ventricular systolic pressure
atio is less than 0.6. If this is not possible we perform a
imited ventriculotomy, which is reconstructed with a
ransannular patch. Since the description of the pulmonary
usp augmentation technique by Sung and associates3 in
003, we have adopted this technique for patients requiring
transannular patch. This technique preserves the native
inge mechanism of the valve cusps, especially when the
ulmonary valve is bicuspid and the commissures are lo-
ated in the 3 and 9 o’clock positions. The use of native
alve tissue also offers the theoretic potential of growth.
he pulmonary valve cusp augmentation technique effec-
ively reduces the degree of postoperative PI. Of 18 patients
ho had relief of RVOT obstruction with the use of the
ulmonary valve cusp augmentation technique, 5 (27%) had
oderate or severe PI at discharge. In contrast, 84% of the
atients with transannular patch reconstruction had clini-
ally significant PI at discharge. In the series published by
ung and associates,3 all 18 patients had absent or mild PI
t discharge. It is not clear whether the higher incidence of
I in our series is because of technical reasons (ie, a learning
urve) or because the patients in Sung’s series were older
mean age 13.8 months).
The pulmonary neocusp technique can be used in the
ajority of patients with TOF and pulmonary stenosis who
equire division of the pulmonary valve annulus for relief of
raphic data
sp augmentation
18
TAP
n  25 P
1-3) 3 d (1-86) .001*
2 (8%) .33
5%) 3 (12%) .43
16%) 11 (44%) .05*
5%) 13 (52%) .001*
17%) 11 (44%) .05*
1-6) 8 d (2-86) .001*
4-20) 10 d (6-86) .08*
g (0-60) 15.5 mm Hg (0-73) .34
27%) 21 (88%) .001*
5%) 10 (40%) .005*
unit; RVOT, right ventricular outflow tract; PI, pulmonary insufficiency; TR,rdiog
lve cu
n 
1 d (
0
1 (
3 (
1 (
3 (
2 d (
.5 d (
mm H
5 (
1 (
careVOT obstruction. In our experience it cannot be applied
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Dnly in a certain subgroup of patients who have a small
ulmonary annulus with hypoplastic inadequate native pul-
onary valve tissue. In this group of patients the transatrial–
ranspulmonary repair with a minimal right ventriculotomy
nd closure of the RVOT with a simple transannular patch
s our preferred technique.
The acute change from a pressure-loaded to a volume-
oaded right ventricle in addition to the right ventriculotomy
fter a transannular patch reconstruction can adversely af-
ect the performance of the right ventricle in the immediate
ostoperative period.21,30 Our patients who underwent pul-
onary valve cusp augmentation had a far better postoper-
tive course when compared with the patients with a
ransannular patch reconstruction. They stayed intubated for
shorter period of time, required less inotropic support, had
ewer persistent pleural effusions and chylothoraces, and
ad fewer postoperative supraventricular arrhythmias. Tur-
entine and associates,22 using a polytetrafluoroethylene
onocusp valve for RVOT reconstruction, effectively de-
reased the degree of PI compared with their patients who
eceived a nonvalved transannular patch. They also found a
ignificant difference in ICU use and a trend toward better
urvival in favor of the patients with a monocusp. In con-
rast, a study from Toronto failed to show any advantage in
he postoperative course of patients who had a monocusp
alve creation as part of their TOF repair. In this study,
owever, the degree of postoperative PI was similar in the
atients who had a monocusp valve constructed and the
atients who underwent transannular patch reconstruction.31
Seventeen percent of our patients had progression of PI
n short-term follow-up (median 7.5 months). In Sung and
olleagues’3 series, 2 of the 18 patients also had progression
f PI at the 10-month follow-up. We will continue to follow
hese patients to determine whether this reconstruction is
urable or not.
The limitations of the study include its retrospective
onrandomized nature. Although there are no demographic,
linical, and echocardiographic parameters that differed
etween the 2 groups, it is possible there is selection bias
hat influenced the results of this study. In addition, al-
hough there is a considerable overlap in the use of the 2
echniques in our institution, the majority of the patients
ho had pulmonary neocusp reconstruction underwent op-
ration after the introduction of the technique by Sung and
ssociates in 2002.3 It is possible that part of the improve-
ent in clinical outcome may reflect this time discrepancy.
lso, as mentioned above, we have no data on the long-term
utcome for these patients or for the durability of the repair,
oth of which we will assess over time.
Despite all of the limitations of our study, the augmen-
ation of the pulmonary valve cusp with autologous pericar-
ium is simple, does not significantly prolong the operation,
educes the degree of PI in the immediate postoperative
1
The Journal of Thoraciceriod, and improves the early outcome after transatrial–
ranspulmonary TOF repair requiring a transannular patch.
hen technically feasible, it has become our preferred
echnique for RVOT reconstruction in patients with TOF
nd in patients with pulmonary stenosis who require surgi-
al intervention.
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iscussion
r J. Brown (Indianapolis, Ind). We at Indianapolis completely
gree with your comments that you should try to reconstruct the
ulmonary valve every time you have to cross the annulus. We
ave used the polytetrafluoroethylene (Gore-Tex; WL Gore and
ssociates, Flagstaff, Ariz) monocusp.
The illustrations in your presentation look similar to the illus-
rations of the monocusp with the exception that you sew the edge
f your pericardial patch augmentation to the residual cut edges of
he leaflet that you cut across. And when your annulus is only 6
m, and I look at those valves, they’re so dysplastic, sewing a
ericardial patch to the edges of the leaflets just seems kind of
ifficult in a 3-, 4-, or 5-month-old child. So I wonder, the patches
hat you actually sew into these patients must be much wider than
he rest of the cusps put together to get an annulus diameter big
nough for that child.
When we originally started using polytetrafluoroethylene
Gore-Tex) monocusps, we sewed them to the pulmonary artery
all rather than the residual leaflet tissue. They were big enough
o be draped across the back of the RVOT so that it made it a
onocusp. How do your patch dimensions compare with our
olytetrafluoroethylene (Gore-Tex) monocusps? We know that our
olytetrafluoroethylene (Gore-Tex) monocusps last 2 or 3 years,
nd I am interested to find out whether these pericardial cusp s
46 The Journal of Thoracic and Cardiovascular Surgery ● Marcugmentations will last even a longer period of time. So that’s the
rst question. Is there really a difference between your technique
nd what we’ve been doing for 10 or 12 years?
Dr Anagnostopoulos. I think the difference is that by suturing
he pericardial tissue into the native valve apparatus, we try to use
he hinge mechanism of the valve and make it coapt with the rest
f the tissue. That cannot be done in the subset of patients in whom
he annulus is less than 4 or 5 mm, and in very dysplastic valves.
n these patients, the transannular patch is still our technique of
hoice.
To answer your question, I think, yes, our cusp is bigger than
he monocusp, the way I understand it by looking at your illustra-
ions. The monocusp is a technique that we don’t use at UCSF. The
ericardium is more pliable and gives you more lead to be able to
se a wider patch than the traditional monocusp.
Dr Brown. My second question is that at least in people who
ave used a biologic monocusp, a cusp from a homograft, autol-
gous pericardium, or bovine pericardium, none of them have
emained functional after about 3 or 4 months. Your follow-up is
.5 months, on average, with a follow-up of more than 2 years. Do
ou think your monocusps for some reason are going to be more
urable than those of everybody else who has tried the biologic
onocusp?
Dr Anagnostopoulos. The only reason why this could happen,
f it does (and as you said, we don’t have the data yet), is because
t is attached to the valve tissue itself. The theoretic potential of
rowth of the remaining native valve tissue exists. I think only
ime will tell.
Dr Brown. About 25 patients, or 27% of your patients, who
ad the cusp augmentation had moderate to severe PI. What do
hose cusps that failed look like? Are they fixed in the open
osition, as I would expect? Are they still mobile and they just
eren’t sized right? Why do 25% of your patients have moderate
o severe PI early after operation?
Dr Anagnostopoulos. They are fixed in the open position as
ou described. This probably represents technical problems with
he construction of this pericardial cusp augmentation flap. It
ostly happened in the beginning of our experience. Dr Sung, in
is article, quotes a similar problem in 2 of his 18 patients. The rate
f deterioration in his study was 17% in 2 years and was 17% in
urs as well. So I think that it had to do with the way we did it, and
think we learned better how to do that as time went by. I don’t
emember, in the last part of our experience, seeing that problem
nymore. That was part of our learning curve with the technique.
Dr Brown. I congratulate you and your group for attempting to
econstruct the pulmonary valve in every transannular patch re-
onstructive. We totally agree. I think time will only tell whether
his biologic cusp augmentation is going to have the same fate that
thers have or whether it will be better.
Dr Y. Kawashima (Minoo City, Japan). I congratulate Dr
nagnostopoulos and his coauthors for their excellent results of
ransatrial–transpulmonary repair for patients with TOF, particu-
arly in patients who underwent pulmonary valve augmentation.
s you may know, I started this transatrial–transpulmonary repair
or TOF in 1978, and I have simultaneously repaired the stenotic
ulmonary valve precisely using the cusp augmentation technique
ith an autologous pericardium when necessary with a methodimilar to that reported today.
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DRecently I reviewed the late result of the initial 110 patients
ho underwent operation 16 to 28 years ago at the age of 5 years
r less. There was 1 operative death, and 1 patient died 18 years
fter surgery. Among the other 108 patients, followed on an
verage of 22 years, 8 patients underwent reoperation, 7 for
ecurrent infundibular stenosis and 1 for calcified annular patch;
owever, no patient underwent reoperation for pulmonary regur-
itation.
I presume this is because of the somewhat functioning repaired
alve and a slightly enlarged pulmonary annulus. Excessive en-
argement of the pulmonary annulus was not necessary in our
eries because of the initially functioning pulmonary valve.
I agree with the author’s conclusion that pulmonary valve
epair using the cusp augmentation technique reduces the inci-
ence of postoperative pulmonary regurgitation, and my conclu-
ion is that precisely performed cusp augmentation reduces pul-
onary regurgitation even on an average of 22 years after surgery.
Dr Anagnostopoulos. Thank you for those comments.
Dr M. Wojtalik (Poznan, Poland). According to the drawing
ou have presented, it seems that there are 2 large patches recon-
tructing the RVOT, 1 inside creating the cusp and 1 outside. I
ould be afraid about the creation of the clotting between and
bstructing the RVOT. Did you observe such a complication?
Dr Anagnostopoulos. We followed those patients, and at this
edian follow-up of 8 months we haven’t seen any clots. One
atient had to undergo reoperation for residual RVOT obstruction,
ut during the operation it was clear that this was because of the
bstructing muscle fibers in the outflow and not because of the
usp obstructing the valve at the valvar level.
Dr S. Bradley (Charleston, SC). What do you and Dr Karl
hink are the best anatomic selection criteria for using this tech-
ique? It sounds like it would be difficult to use with a very small
ulmonary valve (a z score of 4 or so) or a stenotic unicusp
alve, as opposed to a valve that was mildly stenotic (z scores of
2 to 3). Is that fair, and do you have those criteria?
Dr Anagnostopoulos. Yes, that’s fair. The ideal valve for this
echnique is one that has the commissures at the 3 and 9 o’clock
ositions so the anterior leaflet can be bisected in the midline.
hose are anything from 50% to 70% of the valves, according to
r Kawashima’s study from 1981, and according to Steward and i
The Journal of Thoracicolleagues’ series from last year that was presented at the Society
f Thoracic Surgeons meeting. So I think it can be done. When the
ommissures are aligned at the 6 and 12 o’clock positions and you
ut through the anterior commissure, there is not a lot of valve to
ew and you end up reconstructing the RVOT with what looks
ore than a monocusp valve. But when you have valves that are
riented at the 3 and 9 o’clock positions, then you can really do it
ecause there is a nice remnant to sew your valve augmentation
ap on.
Dr A. Schlichter (Buenos Aires, Argentina). I have a short
omment and 1 question:
First, it takes a little longer to apply 2 patches than only 1. What
e do is prepare our patch with untreated pericardium, adapted to
he exact size that the patient needs to have the pulmonary artery
nd annulus enlarged, according to tables and body surface area.
aving measured the patient’s annulus, a resident produces the
onocusp on the patch, and we then suture the patch on the
nnulus.
Are you taking into consideration the diameter that you need to
btain for the enlarged pulmonary annulus and artery? I am asking
his because we are now concerned about long-standing pulmonary
alve incompetence, which is in relation to the diameter of the
ulmonary artery at the time of its surgical enlargement. If we enlarge
t too much, we are probably going to have more PI in the long term
nd more reoperations for TOF. It has been some time since we
hanged our policy of wide enlargements, and we now prefer to
ailor patches to the patient’s needs or even a little smaller. In the
ong term we think it is better to have a nonsignificant pressure
radient than severe pulmonary valve incompetence.
Dr Anagnostopoulos. When we construct that patch, we have
n mind what the pulmonary valve annulus should be for that
articular patient. To not prolong the operation, you cannot really
ave it preformed and suture it on because you have to be able to
ee the valve. Otherwise you can end up creating technical prob-
ems; you can tear those valves that sometimes are dysplastic and
ery thinned out.
To do that, we snare the patent foramen ovale, and then we do
his part of the reconstruction on the beating heart. So even though
t may take some more time, at least that’s not ischemia time.
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